SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nutraplus India - Quaterly Results

21 Sep 2024 Evaluate
The Sales for the quarter ended June 2020 of Rs. 0.09 million declined by -99.97% from Rs. 315.86 millions.The Net Loss for the quarter ended June 2020 is Rs. -12.78 millions as compared to Net Profit of Rs. 1.76 millions of corresponding quarter ended June 2019Operating profit Margin for the quarter ended June 2020 slipped to -0.12% as compared to 29.52% of corresponding quarter ended June 2019


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202006 201906 % Var 202006 201906 % Var 202003 201903 % Var
Sales 0.09 315.86 -99.97 0.09 315.86 -99.97 1066.69 1395.56 -23.57
Other Income 0.30 0.38 -21.05 0.30 0.38 -21.05 1.44 38.76 -96.28
PBIDT -0.12 29.52 -100.41 -0.12 29.52 -100.41 -356.93 165.29 -315.94
Interest 0.68 15.96 -95.74 0.68 15.96 -95.74 74.32 68.52 8.46
PBDT -0.80 13.56 -105.90 -0.80 13.56 -105.90 -431.25 73.92 -683.40
Depreciation 11.98 11.80 1.53 11.98 11.80 1.53 47.01 40.30 16.65
PBT -12.78 1.76 -826.14 -12.78 1.76 -826.14 -478.26 33.62 -1522.55
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.74 -100.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.52 -100.00
PAT -12.78 1.76 -826.14 -12.78 1.76 -826.14 -478.26 21.88 -2285.83
Equity 170.46 170.46 0.00 170.46 170.46 0.00 170.46 170.46 0.00
PBIDTM(%) -133.33 9.35 -1526.65 -133.33 9.35 -1526.65 -33.46 11.84 -382.52

Nutraplus India Share Price

2.10 0.00 (0.00%)
13-Dec-2021 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×